Frailty phenotype and the role of levodopa challenge test in geriatric inpatients with mild parkinsonian signs

[1]  H. Vanderstichele,et al.  Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs , 2016, Alzheimer's Research & Therapy.

[2]  K. Wilczyński,et al.  Fried frailty phenotype assessment components as applied to geriatric inpatients , 2016, Clinical interventions in aging.

[3]  K. Nakashima,et al.  Longitudinal course of mild parkinsonian signs in elderly people: A population-based study in Japan , 2016, Journal of the Neurological Sciences.

[4]  G. Kojima.  Frailty as a Predictor of Future Falls Among Community-Dwelling Older People: A Systematic Review and Meta-Analysis. , 2015, Journal of the American Medical Directors Association.

[5]  Manuel Rodriguez,et al.  The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging , 2014, Front. Neuroanat..

[6]  Jeannette R. Mahoney,et al.  Contributions of mild parkinsonian signs to gait performance in the elderly , 2014, AGE.

[7]  Walter Maetzler,et al.  Mild Parkinsonian Signs in the Elderly – Is There an Association with PD? Crossectional Findings in 992 Individuals , 2014, PloS one.

[8]  Kenneth Rockwood,et al.  Operationalization of Frailty Using Eight Commonly Used Scales and Comparison of Their Ability to Predict All‐Cause Mortality , 2013, Journal of the American Geriatrics Society.

[9]  Manuel Rodriguez,et al.  Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease , 2013, The European journal of neuroscience.

[10]  R. Romero-Ortuño.  The Frailty Instrument for primary care of the Survey of Health, Ageing and Retirement in Europe predicts mortality similarly to a frailty index based on comprehensive geriatric assessment , 2013, Geriatrics & gerontology international.

[11]  S. Iliffe,et al.  Frailty in elderly people , 2013, The Lancet.

[12]  A. Antonini,et al.  EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease , 2013, European journal of neurology.

[13]  E. Junn,et al.  The role of oxidative stress in Parkinson's disease. , 2013, Journal of Parkinson's disease.

[14]  Gareth R. Jones,et al.  Physical Activity across Frailty Phenotypes in Females with Parkinson's Disease , 2012, Journal of aging research.

[15]  Meredith N. Braskie,et al.  Dopamine and frontostriatal networks in cognitive aging , 2012, Neurobiology of Aging.

[16]  A. Cuervo,et al.  Selective autophagy in the maintenance of cellular homeostasis in aging organisms , 2012, Biogerontology.

[17]  G. Paolisso,et al.  Frailty and muscle metabolism dysregulation in the elderly , 2010, Biogerontology.

[18]  M. Makary,et al.  Frailty as a predictor of surgical outcomes in older patients. , 2010, Journal of the American College of Surgeons.

[19]  Katrien G Luijkx,et al.  The Tilburg Frailty Indicator: psychometric properties. , 2010, Journal of the American Medical Directors Association.

[20]  M. Farrer,et al.  Missing pieces in the Parkinson's disease puzzle , 2010, Nature Medicine.

[21]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[22]  Jianqing Ding,et al.  Microglia in the aging brain: relevance to neurodegeneration , 2010, Molecular Neurodegeneration.

[23]  J. Spagnoli,et al.  Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  S. Floresco,et al.  Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility , 2009, Neuropsychopharmacology.

[25]  Paolo Zamboni,et al.  Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.

[26]  Scott J Sherman,et al.  Frailty in Parkinson's disease and its clinical implications. , 2008, Parkinsonism & related disorders.

[27]  Ross T Tsuyuki,et al.  Validity and reliability of the Edmonton Frail Scale , 2006, Age and ageing.

[28]  S. Floresco,et al.  Mesocortical dopamine modulation of executive functions: beyond working memory , 2006, Psychopharmacology.

[29]  Robert W. Taylor,et al.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.

[30]  S. Floresco,et al.  Multiple Dopamine Receptor Subtypes in the Medial Prefrontal Cortex of the Rat Regulate Set-Shifting , 2006, Neuropsychopharmacology.

[31]  Kenneth Rockwood,et al.  Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[32]  Kenneth Rockwood,et al.  Operationalizing a Frailty Index from a Standardized Comprehensive Geriatric Assessment , 2004, Journal of the American Geriatrics Society.

[33]  Siegwart Lindenberg,et al.  Old or frail: what tells us more? , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[34]  Lars Nyberg,et al.  Cognitive aging : a view from brain imaging , 2004 .

[35]  Nick C Fox,et al.  A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. , 2003, Archives of neurology.

[36]  H. Katinger,et al.  Age-related alterations in the protein expression profile of C57BL/6J mouse pituitaries , 2002, Experimental Gerontology.

[37]  L. Fried,et al.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[38]  J. Cummings,et al.  Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. , 2002, Journal of psychosomatic research.

[39]  M. Merello,et al.  Accuracy of acute levodopa challenge for clinical prediction of sustained long‐term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis , 2002, Movement disorders : official journal of the Movement Disorder Society.

[40]  Kathleen Koenig,et al.  Serum Interleukin‐6 and Hemoglobin as Physiological Correlates in the Geriatric Syndrome of Frailty: A Pilot Study , 2002, Journal of the American Geriatrics Society.

[41]  T. van Amelsvoort,et al.  HRT and its effect on normal ageing of the brain and dementia. , 2001, British journal of clinical pharmacology.

[42]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[43]  L. Svennerholm,et al.  Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes , 1997, Acta Neuropathologica.

[44]  L A Beckett,et al.  Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.

[45]  L. Radloff.  The CES-D Scale , 1977 .

[46]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.